News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
137 Results
Type
Article (2)
Company Profile (1)
Press Release (134)
Section
Business (42)
Deals (10)
Drug Development (20)
FDA (2)
Job Trends (1)
News (64)
Policy (1)
Tag
Alliances (5)
Approvals (2)
Best Places to Work (1)
Breast cancer (14)
Cancer (15)
Clinical research (26)
Data (9)
Earnings (41)
Events (49)
FDA (5)
Funding (1)
IPO (10)
Medical device (1)
Medtech (1)
Patents (1)
People (8)
Phase 1 (12)
Phase 2 (4)
Phase 3 (13)
Pipeline (5)
Preclinical (4)
Prostate cancer (1)
Regulatory (4)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (30)
2026 (2)
2025 (28)
2024 (18)
2023 (27)
2022 (18)
2021 (31)
2020 (8)
2019 (2)
2017 (3)
Location
California (1)
Europe (1)
Minnesota (52)
Southern California (1)
United States (52)
137 Results for "celcuity".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
·
2 min read
Press Releases
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
November 27, 2025
·
2 min read
Press Releases
Celcuity To Present at Upcoming Stifel 2025 Healthcare Conference
November 4, 2025
·
2 min read
Press Releases
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
January 20, 2026
·
6 min read
Press Releases
Celcuity Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
·
16 min read
Press Releases
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
November 5, 2025
·
2 min read
Press Releases
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
December 12, 2025
·
6 min read
Press Releases
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
November 27, 2025
·
2 min read
Press Releases
Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
November 18, 2025
·
7 min read
Press Releases
Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 15, 2025
·
15 min read
1 of 14
Next
